CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
GLYCOVAX is focused on training young scientists to design innovative glycoconjugate vaccines that enhance immunogenicity and safety. By combining expertise in carbohydrate synthesis and immunology, the project aims to create a new generation of vaccines to address unmet medical needs, particularly in pediatric care.
GLYCOVAX is a network for the education of promising young scientists who will learn how to rationally design a next generation of well-defined and innovative glycoconjugate vaccines to improve current preventive therapies and to tackle unmet medical needs.
Glycoconjugate vaccines represent the key for success of vaccination in children.
The covalent linkage to proteins renders carbohydrates able to evoke a T-cell memory response.
Current vaccines are prepared from heterogeneous mixtures of suga…
GLAXOSMITHKLINE VACCINES SRL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
